Cefpodixime tabletsoral suspensiondt are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: • acute otitis media caused by streptococcus pneumoniae , (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilus influenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains). • pharyngitis andor tonsilis caused by streptococcus pyogenes. Indication : cefpodoxime - 100 mg & 200 mg tablets . Strip pack of 10 tablets cefppdoxime - 50 mg & 100 mg oral suspension . Bottle of 30 ml cefpodoxime dt - 50 mg & 100 mg tablets . Strip pack of 10 tablets strength : 100 mg, 200 mg, dt 50 mg, dt 100 mg